Letter to the Editor
Interpretability and external validation remain key barriers to clinical integration of multimodal deep learning for breast cancer prognosis
Journal of Medical Artificial Intelligence
2026;
9:
40
.
(30 April 2026)
Editorial Commentary
The DeepSeek-R1 moment: democratized intelligence, prompt vulnerabilities, and the dawn of agentic ophthalmology
Journal of Medical Artificial Intelligence
2026;
9:
39
.
(30 April 2026)
Mini-Review
Current state of Food and Drug Administration-approved artificial intelligence/machine learning medical devices: pathways, transparency, and evidence gaps
Journal of Medical Artificial Intelligence
2026;
9:
38
.
(30 April 2026)
Review Article
The utilization of artificial intelligence (AI) and machine learning (ML) for health in Nigeria: a rapid review
Journal of Medical Artificial Intelligence
2026;
9:
37
.
(30 April 2026)
Review Article
Artificial intelligence-augmented electrocardiogram for heart failure diagnosis and risk prediction: a narrative review
Journal of Medical Artificial Intelligence
2026;
9:
36
.
(30 April 2026)
Review Article
Artificial intelligence applications for breast cancer diagnosis in ultrasound: a narrative review
Journal of Medical Artificial Intelligence
2026;
9:
35
.
(30 April 2026)
Original Article
Deep learning precise image reconstruction algorithm for abdominal CT: impact on image quality and radiation dose reduction—a model validation study
Journal of Medical Artificial Intelligence
2026;
9:
34
.
(30 April 2026)
Original Article
Lost in Translation?—comparing ChatGPT’s responses to English and Spanish gastroenterology queries
Journal of Medical Artificial Intelligence
2026;
9:
33
.
(30 April 2026)
Original Article
AI-driven discovery of EZH2 as a core target and potential inhibitors for breast cancer
Journal of Medical Artificial Intelligence
2026;
9:
32
.
(30 April 2026)
Original Article
Design and evaluation of transfer learning models for glioma grade prediction
Journal of Medical Artificial Intelligence
2026;
9:
31
.
(30 April 2026)
